Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary starch molecules are plant-derived polysaccharides made up entirely of D-glucose monomers linked primarily by alpha-glycosidic bonds. They exist mainly as two types—linear amylose (~10–30%) and highly branched amylopectin (~70–90%). Their structural features determine their physical properties in food processing as well as their digestibility—which has direct consequences for human health outcomes related to energy metabolism.
Alpha-amylase and alpha-glucosidase inhibitors slow down the digestion of starch into glucose, reducing postprandial blood glucose levels.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary Starch Molecules.